Report Categories
View AllRecent Articles
View All
ExxonMobil XOM Q4 2025 Earnings Benchmark Against Diversified Upstream EP Peer Group
XPER Xperi Q1 results exceed expectations with EPS surging 83 above estimates fueled by robust media platform adoption
Supernus Pharmaceuticals SUPN Stock Worth Holding Bearish Sentiment 20260420
SPRY ARS Pharmaceuticals posts narrower Q4 2025 loss than estimates stock dips 012 percent in todays trading
Is Caesars CZR stock a buy today Caesars posts 639 EPS miss vs street estimates
MLACR Mountain quarterly filing shows no revenue as acquisition pipeline remains central focus for SPAC investors
FCC Broadcast License Regulatory Action and Media Sector First Amendment Implications
The recurring revenue story behind KRAKacquisition KRAQ
HEI Heico Corporation posts narrow Q1 2026 EPS beat shares dip 11 on lukewarm investor reception
CapCity Bank CCBG Slips 176 Testing 4306 Support 20260515
Cemtrex CETX Q3 2024 Earnings Miss EPS 018 vs 007 Expected
30Year Treasury Yield Surges Past 519 Reaching Levels Last Seen Before the 2008 Financial Crisis
US Museums Drive Cultural Tourism and Economic Impact
Target Observes Unexpected Change in Customer Behavior
OneMain Holdings OMF Q1 2026 Earnings Beat Revenue NA EPS 195
Indian Stock Markets Surge Sensex Jumps Over 600 Points Nifty 50 Reclaims 23850
International Court Ruling on Indus Waters Treaty May Reshape Regional Water Dynamics
FRAF Q1 2026 Earnings Earnings Beat Estimates on 828 Surprise Shares Edge Higher
Seanergy Maritime Holdings Corp SHIP Q4 2025 Earnings Strong EPS Beat Amid Dry Bulk Sector Headwinds
Assurant AIZ Q1 2026 Earnings EPS Surges 11 Above Estimates as Underwriting Strength Drives Profit
AstroNova Inc Q1 2026 Earnings A Loss Per Share Amid Quiet Revenue Disclosure
PSX Q1 2026 Earnings EPS Surges Past Estimates Driven by Operational Strength
AiRWA Inc YYAI Holds Ground Near Support After Minor Dip
Investcorp Credit Management BDC Inc ICMB Edges Higher Amid Tight Trading Range
Donnelley Financial Solutions DFIN Edges Lower as It Tests Key Support at 3680
Ionis Pharmaceuticals Holds Steady Near Support as Biotech Sector Eyes Catalysts